Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2006-02-21
2006-02-21
Shukla, Ram R. (Department: 1632)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C435S320100
Reexamination Certificate
active
07001596
ABSTRACT:
Viral vectors and methods of making such vectors are described that preferentially kill neoplastic but not normal cells, the preferred vector being an adenovirus that has the endogenous promoters in the E1A and/or E4 regions substituted with a tumor specific promoter which is preferably E2F responsive.
REFERENCES:
patent: 5677178 (1997-10-01), McCormick
patent: 5801029 (1998-09-01), McCormick
patent: 5885833 (1999-03-01), Zwicker Joerk et al.
patent: 5998205 (1999-12-01), Hallenbeck
patent: 6204052 (2001-03-01), Bout
patent: 6432700 (2002-08-01), Henderson
patent: 6436394 (2002-08-01), Henderson
patent: 6544507 (2003-04-01), Iggo et al.
patent: 2001/0053352 (2001-12-01), Yu
patent: 2002/0150557 (2002-10-01), Ramachandra
patent: 2003/0026789 (2003-02-01), Gregory
patent: WO 94/18992 (1994-09-01), None
patent: WO 98/13508 (1998-04-01), None
Russell (European Journal of Cancer, vol. 30A, 8:1165-1171, Aug. 1994).
Miller et al. (Human Gene Therapy, vol. 8, pp. 803-815, 1997).
Vile et al. (Molecular Medicine Today, vol. 4, 2:84-92, 1998).
Gomez-Navarro et al. (European J. of Cancer, vol. 35, 6:867-885, 1999).
Yanez (Gene Therapy, 5:149-159, 1998).
Anderson (Nature, vol. 392, pp. 25-30, Apr. 1998).
Mastrangelo et al. (Seminars in Oncology, vol. 23, No. 1:4-21, 1996).
Meng et al. (Gene Therapy of Cancer, Chapter I, pp. 3-20, 1999).
Rosenberg, Science, vol. 287, p. 1751, 2000.
Swaminathan S. and Thimmapapya B., “Transactivation of Adenovirus E2-Early Promoter by E1A and E4 6/7 in the Context of Viral Chromosome” (1996) J. Mol. Biol. vol. 258, p. 736-746.
Fattaey Ali
Hermiston Terry
Johnson Leisa
Giotta Gregory
Montanari David A.
Onyx Pharmaceuticals Inc.
Shukla Ram R.
LandOfFree
Oncolytic adenovirus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oncolytic adenovirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oncolytic adenovirus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3647296